If approved, the ADC would join sacituzumab govitecan (Trodelvy, Gilead) as agents that target trophoblast cell-surface antigen-2 (Trop-2), which is universally expressed in breast cancer.
Cynthia X. Ma, MD, PhD, discusses updates in triple-negative breast cancer treatment, recent data on HER2-targeted agents in metastatic and early-stage HER2-positive breast cancer, and the role of CDK4/6 inhibitors and oral selective estrogen receptor degraders in hormone receptor–positive disease.
Breast cancer treatments are changing patients lives suntimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from suntimes.com Daily Mail and Mail on Sunday newspapers.
World Health Day: Local man gives thanks to NHS a year on from heart attack April 7 2021, 3.04pm
A Fife man has thanked NHS and charity staff to mark World Health Day, a year on from experiencing a heart attack.
Ron Bose, from Rosyth, experienced a heart attack in April last year, just after the country went into lockdown due to the coronavirus pandemic.
The 77-year-old explains: “I thought myself reasonably healthy. I used to go for daily walks and do plenty of exercise.
“In March last year I occasionally felt a tightness in my chest, but it didn’t feel like anything in particular. I ignored it for a bit.